CYP24A1 and neoplasm: To the best of our knowledge, this is the first bis-ureido-substituted primary benzenesulfonamide study, which examined the inhibition profile of these compounds on selected hCAs, namely off-target cytosolic isoforms hCA I and II, and tumour-overexpressed membrane-bound isoforms hCA IX and XII.